Biotin-FF-FMK contains a diphenylalanine motif with an FMK reactive group and biotin label. The aromatic pair promotes interactions with hydrophobic protease pockets. Researchers utilize it to capture active enzymes and analyze substrate specificity. Its dual-tag architecture supports affinity-based biochemical workflows.
CAT No: HB00023
Biotin-FF-FMK is a biotinylated, irreversible fluoromethyl ketone (FMK) peptide inhibitor designed for research applications in protease biology and apoptosis studies. As a synthetic peptide-based compound, it features a biotin tag for affinity capture and a fluoromethyl ketone reactive group that covalently modifies active site cysteine residues in target proteases, particularly those within the caspase family. The dual functionality of this molecule enables both selective enzyme inhibition and robust detection or isolation via biotin-streptavidin interactions, making it a valuable tool for dissecting proteolytic pathways and protein-protein interactions in cellular systems. Its well-defined structure and specific reactivity profile have established it as a preferred reagent for mechanistic studies in cell death, enzymology, and proteome analysis.
Enzyme Activity Profiling: Biotin-FF-FMK is extensively employed in the selective inhibition and profiling of cysteine proteases, with a primary focus on caspases. By covalently binding to the active site of these enzymes, the inhibitor effectively blocks their catalytic activity, allowing researchers to dissect the functional roles of individual caspases in programmed cell death and related signaling pathways. The irreversible nature of its FMK moiety ensures that target enzymes are permanently inactivated, which is critical for generating unambiguous biochemical data in time-course studies or endpoint assays.
Affinity-Based Proteomics: The biotin tag incorporated into this peptide inhibitor facilitates powerful affinity purification strategies. Following treatment of cell lysates or intact cells, biotin-FF-FMK-labeled proteases can be selectively captured using streptavidin-coated beads or matrices. This approach enables the enrichment and subsequent identification of active protease populations from complex biological samples by downstream techniques such as SDS-PAGE, Western blotting, or mass spectrometry. As a result, it supports the comprehensive mapping of protease activity states and the discovery of novel regulatory proteins or substrates.
Mechanistic Apoptosis Research: The compound is widely used to interrogate the molecular mechanisms underlying apoptosis. By specifically targeting caspase activity, it provides a means to modulate and monitor the execution phase of programmed cell death in various model systems. Researchers can utilize this inhibitor to delineate caspase-dependent versus caspase-independent pathways, assess the temporal sequence of protease activation, and validate the involvement of specific caspases in cellular responses to apoptotic stimuli. Such studies are fundamental for advancing our understanding of cell fate decisions and apoptotic signaling networks.
Activity-Based Probe Development: Biotin-FF-FMK serves as a prototypical scaffold for the design and optimization of activity-based probes (ABPs) targeting cysteine proteases. Its modular structure and functional groups allow for adaptation and modification, supporting the creation of custom probes with altered specificity or enhanced detection capabilities. Researchers leverage this compound as a reference or starting point in the development of new ABPs for high-throughput screening, target validation, or in vivo imaging of protease activity.
Cellular Pathway Dissection: The ability of this biotinylated FMK inhibitor to irreversibly inactivate target proteases enables precise manipulation of proteolytic events within living cells or in vitro systems. By applying it in combination with other biochemical tools or genetic approaches, investigators can systematically dissect signaling cascades and protein turnover mechanisms governed by caspase or related protease activity. This facilitates the elucidation of complex biological processes such as inflammation, differentiation, and stress responses, providing a deeper understanding of protease function in health and disease at the molecular level.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More